Compare GSK plc (GSK) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Realty Income Corp — how do they compare? GSK plc trades at $50.19 (market cap $102.60B), while Realty Income Corp trades at $62.25 (market cap $58.56B). The key difference: GSK plc is the larger of the two by market cap, and Realty Income Corp pays the higher dividend (5.25%). Which is the better fit depends on your goals.
| GSK | O | |
|---|---|---|
Market Cap | $102.60B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $61.18 | $67.56 |
52-Week Low | $38.22 | $55.93 |
Enterprise Value | $123.04B | $89.19B |
Dividend Yield | 3.57% | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.16, down 1.51% today, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $1.36 per share, beating estimates, and announced a $2.52 billion cost-saving plan to accelerate drug development. Revenue growth remains steady, with 2025 revenue at $32.67 billion and net income of $5.72 billion, though profit margins have fluctuated in recent years.
Outlook is positive with continued earnings beats and strategic investments, but risks include competitive pressures and regulatory uncertainties. Analyst sentiment is mixed with 31% buy ratings, 55% hold, and 14% sell, reflecting cautious optimism amid execution risks and market volatility.
Realty Income (O) trades at $61.89, down 0.99% for the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported Q2 2026 EPS of $0.37, missing the $0.3977 estimate, but raised full-year AFFO guidance. Recent news highlights a $875 million convertible notes offering and a $6 billion hyperscale data center joint venture, supporting growth initiatives amid a 98.8% portfolio occupancy rate.
Outlook remains supported by dividend growth—115 consecutive quarterly increases—and a $10 billion investment target, though elevated debt levels and interest rate sensitivity pose risks. Analysts maintain a consensus price target of $67.29, implying ~9% upside, with 41% buy ratings reflecting cautious optimism for the REIT's income stability and expansion into data centers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
